iTeos Therapeutics

iTeos Therapeutics is one of the...

• Russell 3000.

iTeos Therapeutics is a company listed under the stock ticker ITOS (US).

View the org chart displaying its 18 main executives

Most searched biographies at iTeos Therapeutics

• Michel Detheux, Chief Executive Officer and Director
• Derek DiRocco, Director
• Tony Ho, Director

Popular executive movements at iTeos Therapeutics

• Jill Desimone has joined the company as Director  (posted on March 7 2024).
• David Lee has joined the company as Director  (posted on December 8 2023).

Create your alert
to follow the executive moves at iTeos Therapeutics.

iTeos Therapeutics has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by iTeos Therapeutics

• iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference | iTeos Therapeutics
• iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates | iTeos Therapeutics
• Cancer Immunotherapy & Immunosuppression | iTeos Therapeutics
• Cancer Immunotherapy & Immunosuppression | iTeos Therapeutics

Social media about iTeos Therapeutics

• iTeos Therapeutics on Wikipedia, Google News & Yahoo Finance
• iTeos Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Michel Detheux

Call iTeos Therapeutics at +32 ...

View the org chart

Register to receive your alert

Report an error